Bristol Myers to pay $1.5 billion dollars, upfront, in conjunction with BioNTech for cancer medicine
In a deal that could be worth over 11 billion dollars for the German company, Bristol Myers Squibb announced Monday...
In a deal that could be worth over 11 billion dollars for the German company, Bristol Myers Squibb announced Monday...